Down 24% In A Month, Will Arvinas Stock Rebound?

Published on 2 Jun 2022 on Forbes

Larger pharmaceutical companies, Sanofi and Roche, have seen failures in their clinical trials for cancer treatments using oral selective estrogen...

Read the rest of the article

Start tracking your investments with Statfolio

Novavax received an upfront payment of $500 million and up to $700 million in additional...

Investor's Business Daily 21 Nov 2024

Ariel Investments, an investment management company, released its “Ariel Global Fund” third-quart...

Insider Monkey · via Yahoo Finance 20 Nov 2024

We recently compiled a list of the 10 Best German Stocks To Buy Now. In this article, we are goin...

Insider Monkey · via Yahoo Finance 20 Nov 2024

We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we ...

Insider Monkey · via Yahoo Finance 20 Nov 2024

The FDA had issued a complete response letter (CRL) for the first sBLA seeking approval of Dupixe...

Zacks · via Yahoo Finance 18 Nov 2024

Its stock in the US tumbled almost five percent. GSK saw their shares go down almost four percent...

The Independent · via Yahoo Finance 15 Nov 2024

Companies that make immunizations bore the brunt of the losses, with France’s Sanofi SA - a maker...

The Boston Globe 15 Nov 2024

Have a confidential tip for our reporters? Pharmaceutical stocks declined as President-elect Dona...

Bloomberg 15 Nov 2024

Have a confidential tip for our reporters? European stocks fell as traders pared back expectation...

Bloomberg 15 Nov 2024

(Bloomberg) -- Health stocks slumped on Friday as Wall Street weighed the impact that prominent...

Bloomberg · via Yahoo Finance 15 Nov 2024